ALEXIS HUFF: Open Payments
NPI 1336748425 · MOOSIC, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 95 payments from 15 companies in 2025. Trend: 2023 $1,991 · 2024 $1,799 · 2025 $1,441
Food & beverage: $1,441
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $191 |
| Alkermes, Inc. | 10 | $185 |
| Teva Pharmaceuticals USA, Inc. | 16 | $181 |
| ABBVIE INC. | 13 | $178 |
| Neurocrine BioSciences, Inc. | 12 | $170 |
| Vanda Pharmaceuticals Inc. | 7 | $152 |
| E.R. Squibb & Sons, L.L.C. | 11 | $146 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Almatica Pharma LLC | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
Products named: VRAYLAR, INGREZZA, ARISTADA, FANAPT, COBENFY, AUSTEDO XR, SPRAVATO, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
